Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina: A meta-analysis

JAMA

Volumn 276, Issue 10, 1996, Pages 811-815

  Oler, Allison ^a   Whooley, Mary A ^a,b   Oler, Jacqueline ^c   Grady, Deborah ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN DERIVATIVE;

ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; PRIORITY JOURNAL; REVASCULARIZATION; STATISTICAL ANALYSIS; SUDDEN DEATH; UNSTABLE ANGINA PECTORIS;

EID: 0029771618     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.10.811     Document Type: Article

References (41)

1. Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro J. Insights into the pathogenesis of acute ischemic syndromes. Circulation. 1988;77:1213-1220.
2. Gazes PC, Mobley E Jr, Fans H Jr, Duncan RC, Humphries GB. Preinfarctional (unstable) angina - a prospective study - ten year follow-up: prognostic significance of electrocardiographic changes. Circulation. 1973;48:331-337.
3. Duncan B, Fulton M, Morrison SL, et al. Prognosis of new and worsening angina pectoris. BMJ. 1976;1:981-985.
4. Rahimtoola SH. Coronary bypass surgery for unstable angina. Circulation. 1984;69:842-848.
5. Cairns JA, Gent M, Singer J, et al. Aspirin, sulfinpyrazone, or both in unstable angina: results of a Canadian multicenter trial. N Engl J Med. 1985; 313:1369-1375.
6. Lewis H Jr, Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration Cooperative Study. N Engl J Med. 1983;309:396-403.
7. The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease: the RISC Group. Lancet. 1990; 336:827-830.
8. Rosenberg RD. Actions and interactions of antithrombin and heparin. N Engl J Med. 1975;292: 146-151.
9. Wallis DE, Boden WE, Califf R, et al. Failure of adjuvant heparin to reduce myocardial ischemia in the early treatment of patients with unstable angina. Am Heart J. 1991;122:949-954.
10. Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med. 1988;319:1105-1111.
11. Cohen M, Adams PC, Hawkins L, Bach M, Fuster V. Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group). Am J Cardiol. 1990;66:1287-1292.
12. Cohen M, Adams PC, Parry G, et al. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users: primary end points analysis from the ATACS trial: Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Circulation. 1994;89:81-88.
13. Holdright D, Patel D, Cunningham D, et al. Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina. J Am Coll Cardiol. 1994;24:39-45.
14. Gurfinkel EP, Manos EJ, Mejail RI, et al. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. J Am Coll Cardiol. 1995;26:313-318.
15. Walter S, Cook R. A comparison of several point estimators of the odds ratios in a single 2×2 contingency table. Biometrics. 1991;47:795-811.
16. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: John Wiley & Sons Inc; 1981.
17. Fisher LD, van Belle G. Biostatistics: A Methodology for the Health Sciences. New York, NY: John Wiley & Sons Inc; 1993.
18. Berlin JA, Laird NM, Sacks HS, Chalmers TC. A comparison of statistical methods for combining event rates from clinical trials. Stat Med. 1989;8: 141-151.
19. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res. 1993;2:121-145.
20. BMDP Statistical Software, Inc. PC90 ed. Los Angeles: University of California Press; 1990.
21. Bishop YMM, Feinberg SE, Holland PW. Discrete Multivariate Analysis: Theory and Practice. Cambridge, Mass: MIT Press; 1975.
22. Cohen M, Parry G, Adams PC, et al. Prospective evaluation of a prostacyclin-sparing aspirin formulation and heparin/warfarin in aspirin users with unstable angina or non-Q wave myocardial infarction at rest. Eur Heart J. 1994;15:1196-1203.
23. Fuchs J, Cannon CP. Hirulog in the treatment of unstable angina: results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial. Circulation. 1995;92:727-733.
24. Serneri GGN, Modesti PA, Gensini GF, et al. Randomised comparison of subcutaneous heparin, intravenous heparin, and aspirin in unstable angina: Studio Epoorine Sottocutanea nell'Angina Instobile (SESAIR) Refrattorie Group. Lancet. 1995; 345:1201-1204.
25. Moise A, Roos M, Roos M. Aspirin versus heparin in the acute phase of unstable angina. Circulation. 1994;90:1107.
26. Theroux P, Waters D, Qiu S, et al. Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation. 1993;88:2045-2048.
27. Cohen M, Xiong J, Parry G, et al. Prospective comparison of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy: Antithrombotic Therapy in Acute Coronary Syndromes Research Group. J Am Coll Cardiol. 1993;22:1338-1343.
28. Averkov OV, Zateishchikov DA, Gratsianskii NA, Dobrovol'skii AV. Unstable angina: tissue-type plasminogen activator inhibitor and other hemostatic factors in aspirin and intravenous heparin administration. Kardiologiia. 1993;33:16-22.
29. Averkov OV, Zateishchikov DA, Gratsianskii NA, Logutov I, Iavelov IS, Ianus V. Unstable angina: effect of aspirin and heparin on treatment outcome in hospital patients (a double-blind, placebo-controlled study). Kardiologiia. 1993;33:4-9.
30. Zwerner PL, Gore JM, Corrao JM, et al. Heparin in the treatment of unstable angina: a randomized prospective trial. Circulation. 1987;76(IV):180.
31. Charvat J, Fiserova J. Anticoagulation and antiaggregation therapy in patients with unstable angina pectoris. Vnitr Lek. 1990;36:537-543.
32. Serneri GGN, Gensini GF, Poggesi L, et al. Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina. Lancet. 1990;335:615-618. Correction: Lancet. 1990;335:868.
33. OASIS. Comparison of hirudin with heparin and warfarin with control for unstable angina and non q wave MI in a randomized controlled trial. Circulation. 1995;92:416.
34. Hirsh J, Raschke R, Warkentin TE, Dalen JE, Deykin D, Poller L. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest. 1995;108:258S-275S.
35. Williams DO, Kirby MG, McPherson K, Phear DN. Anticoagulant treatment of unstable angina. Br J Clin Pract. 1986;40:114-116.
36. Theroux P, Waters D, Lam J, Juneau M, McCans J. Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med. 1992;327:141-145.
37. Granger CB, Armstrong PW. Reinfarction following discontinuation of intravenous heparin or hirudin for unstable angina and acute myocardial infarction. Circulation. 1995;92(81):460.
38. Moher D, Olkin I. Meta-analysis of randomized controlled trials. JAMA. 1995;274:1962-1964.
39. Unstable Angina Panel. Unstable Angina: Diagnosis and Management. Clinical Practice Guideline. Washington, DC: US Dept of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1994. AHCPR 94-0602.
40. The FRISC Study Group. Low-molecular-weight heparin during instability in coronary artery disease: Fragmin During Instability in Coronary Artery Disease (FRISC) Study Group. Lancet. 1996;347:561-568.
41. Barrowcliffe TW. Low molecular weight heparin(s). Br J Haematol. 1995;90:1-7.